Global Hospital & Biosimilars Health System Director Northeast

Role Description

Hospital & Biosimilars Health System Directors are responsible for working with other HSD’s, Field Sales, Marketing, NADs, TADs Contract Development team, Pricing and Commercial Operations team and Strategy and Deployment team and relevant HQ teams to support effective and compliant pricing and contracting discussions with Key Accounts, in support of the biosimilar portfolio. HSDs are expected to effectively and compliantly engage appropriate executive and administrative customers in Key Accounts (with a focus on economic decision makers including Directors of Pharmacy, Office Practice Managers, P&T Committee Members) with respect to the biosimilar pricing and value propositions to secure formulary access and appropriate pull through.  This includes negotiating with the customer when appropriate and facilitating communication and alignment with key HQ functions (Portfolio, Legal, Contract Development team, Pricing and Commercial Operations and Strategy Deployment team) to support GPO, IDN and Distributor Source contracts (including LOC and LOP opportunities) within this space.

In addition to the customer facing responsibility, the HSD will work with their Team Lead to develop Hospital and Biosimilar strategies to capitalize on specific account opportunities within the Region, including leading the effective pull-through efforts in collaboration with AHS team (virtual team) and other customer-facing field functions. The HSD will have a broad view of our Hospital and Biosimilar opportunities and challenges within assigned HSD accounts and will make strategic decisions (in alignment with Leadership) on how to maximize the entire Hospital and Biosimilars portfolio with Key customers. The HSD will also be an active participating member of relevant Regional Account Cross-functional Teams.

Hospital and Biosimilar Key Accounts include, but are not limited to, large community ONC clinics, NCI/Academic institutions, and Oncology service lines within large hospital systems and IDNs.

Responsibilities

• Appropriate communication and collaboration with relevant cross-functional colleagues (HSD’s, HSD Leadership, AHS, Portfolio, Legal, Contract Development team, Pricing and Commercial Operations team and Strategy and Deployment team, Field Sales, et al) to support effective pricing/contracting strategy/discussions with Hospital & Biosimilars Key Accounts.

• Work closely with HSD’s/AHS to ensure development/execution of focused and strategic account plans for all assigned accounts, with specific focus on effective/compliant contracting discussions, and contract pull through. 

• Where needed/appropriate, and as directed by HSD Team Lead, effectively and compliantly engage appropriate customer targets (executive and administrative level personnel within HSD accounts) with respect to pricing/value messages in support of the full Hospital & Biosimilars portfolio (including Oncology and I+I biosimilars products).

• Support the development/execution of effective contracting strategy on behalf of full Biosimilars portfolio, by representing needs/perspectives of HSD accounts to appropriate HQ-based functions/personnel.

• Complies with all Corporate Policies and Procedures, while conducting all job-related activities with integrity and adherence to Pfizer’s high standards of business conduct.

Qualifications

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• 8 years of progressive experience in pharmaceutical sales, medical affairs, and/or corporate account management with customer facing equivalence.

• Including a minimum 3–5 years of direct biosimilars and Generic Sterile Injectables experience, including buy-and-build strategies and demonstrated knowledge of: Regulatory pathways (FDA, EMA, Health Canada) and interchangeability requirements.

  • Manufacturing and quality standards for biologics, amd generic sterile injectables including comparability exercises.

  • Commercialization strategies, market access, IDN and alternate site clinic negotiations, and formulary inclusion for biosimilars.

  • Pharmacovigilance and post-market safety monitoring.

• Preferred: 

  • Oncology and/or Immunology & Inflammation therapeutic area expertise.

  • Proven success engaging Academic Medical Centers, Integrated Delivery Networks (IDNs), and large group practice community accounts.

• Strong understanding of evolving healthcar